Clinical and therapeutic factors associated with adverse pathological outcomes in clinically node-negative patients treated with neoadjuvant cisplatin-based chemotherapy and radical cystectomy

Kamran Zargar-Shoshtari, Homayoun Zargar, Colin P. Dinney, Cesar E. Ercole, Pranav Sharma, Evan Z. Kovac, Petros D. Grivas, Andrew J. Stephenson, Jay B. Shah, Peter C. Black, Philippe E. Spiess

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: Several disease characteristics have been identified as potential predictors for pathological node involvement (pN+) following radical cystectomy (RC). However, these have not been assessed in patients treated with neoadjuvant chemotherapy (NAC). We endeavored to assess factors predicting adverse pathology in clinically node-negative patients treated with NAC and RC. Methods: Patients from four North American institutions with cT2-4aN0M0 UC who received three or four cycles of NAC followed by RC were selected. Logistic regression was used to predict pN+, <pT2 and pT4 disease. Results: One hundred and ninety-six patients were included. The clinical stage was cT2 in 115 (61 %), cT3 in 62 (33 %) and cT4 in 12 (6 %) cases. NAC regiments were gemcitabine–cisplatin (GC)-4 cycles 57 (29 %), GC-3 cycles 77 (39 %), methotrexate, vinblastine, adriamycin, cisplatin (MVAC)-3 cycle 22 (11 %) and MVAC-4 cycles 40 (21 %). pN+ was seen in 35 (18 %) patients. In the logistic regression analysis, cT4 stage (OR 7.50; 95 % CI 1.58–33.3) and three compared to four cycles of GC (OR 3.44; 95 % CI 1.09–10.9) were significant predictors of pN+ status. Additionally, when controlling for clinical stage, three cycles of GC, compared to four, were significantly associated with higher rates of pT4 disease and lower rates of downstaging to non-muscle-invasive disease. Conclusions: The results suggest that four cycles of neoadjuvant GC may be superior to three cycles, and the latter regimen may be associated with adverse pathological findings. Although this would require validation in a prospective trial, it does encourage the completion of the conventional four cycles GC whenever possible.

Original languageEnglish (US)
Pages (from-to)695-701
Number of pages7
JournalWorld Journal of Urology
Volume34
Issue number5
DOIs
StatePublished - May 1 2016
Externally publishedYes

Fingerprint

Cystectomy
Cisplatin
Drug Therapy
Vinblastine
Methotrexate
Doxorubicin
Logistic Models
Therapeutics
Regression Analysis
Pathology

Keywords

  • Cystectomy
  • Neoadjuvant therapy
  • Pathology
  • Prognosis
  • Urinary bladder neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

Clinical and therapeutic factors associated with adverse pathological outcomes in clinically node-negative patients treated with neoadjuvant cisplatin-based chemotherapy and radical cystectomy. / Zargar-Shoshtari, Kamran; Zargar, Homayoun; Dinney, Colin P.; Ercole, Cesar E.; Sharma, Pranav; Kovac, Evan Z.; Grivas, Petros D.; Stephenson, Andrew J.; Shah, Jay B.; Black, Peter C.; Spiess, Philippe E.

In: World Journal of Urology, Vol. 34, No. 5, 01.05.2016, p. 695-701.

Research output: Contribution to journalArticle

Zargar-Shoshtari, Kamran ; Zargar, Homayoun ; Dinney, Colin P. ; Ercole, Cesar E. ; Sharma, Pranav ; Kovac, Evan Z. ; Grivas, Petros D. ; Stephenson, Andrew J. ; Shah, Jay B. ; Black, Peter C. ; Spiess, Philippe E. / Clinical and therapeutic factors associated with adverse pathological outcomes in clinically node-negative patients treated with neoadjuvant cisplatin-based chemotherapy and radical cystectomy. In: World Journal of Urology. 2016 ; Vol. 34, No. 5. pp. 695-701.
@article{6b686409acbc4048a4868081946441c0,
title = "Clinical and therapeutic factors associated with adverse pathological outcomes in clinically node-negative patients treated with neoadjuvant cisplatin-based chemotherapy and radical cystectomy",
abstract = "Purpose: Several disease characteristics have been identified as potential predictors for pathological node involvement (pN+) following radical cystectomy (RC). However, these have not been assessed in patients treated with neoadjuvant chemotherapy (NAC). We endeavored to assess factors predicting adverse pathology in clinically node-negative patients treated with NAC and RC. Methods: Patients from four North American institutions with cT2-4aN0M0 UC who received three or four cycles of NAC followed by RC were selected. Logistic regression was used to predict pN+,",
keywords = "Cystectomy, Neoadjuvant therapy, Pathology, Prognosis, Urinary bladder neoplasms",
author = "Kamran Zargar-Shoshtari and Homayoun Zargar and Dinney, {Colin P.} and Ercole, {Cesar E.} and Pranav Sharma and Kovac, {Evan Z.} and Grivas, {Petros D.} and Stephenson, {Andrew J.} and Shah, {Jay B.} and Black, {Peter C.} and Spiess, {Philippe E.}",
year = "2016",
month = "5",
day = "1",
doi = "10.1007/s00345-015-1667-4",
language = "English (US)",
volume = "34",
pages = "695--701",
journal = "World Journal of Urology",
issn = "0724-4983",
publisher = "Springer Verlag",
number = "5",

}

TY - JOUR

T1 - Clinical and therapeutic factors associated with adverse pathological outcomes in clinically node-negative patients treated with neoadjuvant cisplatin-based chemotherapy and radical cystectomy

AU - Zargar-Shoshtari, Kamran

AU - Zargar, Homayoun

AU - Dinney, Colin P.

AU - Ercole, Cesar E.

AU - Sharma, Pranav

AU - Kovac, Evan Z.

AU - Grivas, Petros D.

AU - Stephenson, Andrew J.

AU - Shah, Jay B.

AU - Black, Peter C.

AU - Spiess, Philippe E.

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Purpose: Several disease characteristics have been identified as potential predictors for pathological node involvement (pN+) following radical cystectomy (RC). However, these have not been assessed in patients treated with neoadjuvant chemotherapy (NAC). We endeavored to assess factors predicting adverse pathology in clinically node-negative patients treated with NAC and RC. Methods: Patients from four North American institutions with cT2-4aN0M0 UC who received three or four cycles of NAC followed by RC were selected. Logistic regression was used to predict pN+,

AB - Purpose: Several disease characteristics have been identified as potential predictors for pathological node involvement (pN+) following radical cystectomy (RC). However, these have not been assessed in patients treated with neoadjuvant chemotherapy (NAC). We endeavored to assess factors predicting adverse pathology in clinically node-negative patients treated with NAC and RC. Methods: Patients from four North American institutions with cT2-4aN0M0 UC who received three or four cycles of NAC followed by RC were selected. Logistic regression was used to predict pN+,

KW - Cystectomy

KW - Neoadjuvant therapy

KW - Pathology

KW - Prognosis

KW - Urinary bladder neoplasms

UR - http://www.scopus.com/inward/record.url?scp=84939483127&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939483127&partnerID=8YFLogxK

U2 - 10.1007/s00345-015-1667-4

DO - 10.1007/s00345-015-1667-4

M3 - Article

C2 - 26286880

AN - SCOPUS:84939483127

VL - 34

SP - 695

EP - 701

JO - World Journal of Urology

JF - World Journal of Urology

SN - 0724-4983

IS - 5

ER -